View in EDS HTML Full Text PDF Full Text

Cardiovascular Hazards of Abacavir- Versus Tenofovir-Containing Antiretroviral Therapies: Insights From an Analysis of the REPRIEVE Trial Cohort.

Saved in:
Bibliographic Details
Title: Cardiovascular Hazards of Abacavir- Versus Tenofovir-Containing Antiretroviral Therapies: Insights From an Analysis of the REPRIEVE Trial Cohort.
Authors: Smith, Emma Davies1 (AUTHOR), Malvestutto, Carlos2 (AUTHOR), Ribaudo, Heather J1 (AUTHOR), Fichtenbaum, Carl J3 (AUTHOR), Aberg, Judith A4 (AUTHOR), Watanabe, Maya1 (AUTHOR), Bloomfield, Gerald S5 (AUTHOR), Currier, Judith S6 (AUTHOR), Chu, Sarah M7 (AUTHOR), Fitch, Kathleen V7 (AUTHOR), Diggs, Marissa R7 (AUTHOR), Bedimo, Roger8 (AUTHOR), Valencia, Javier9 (AUTHOR), Gomez-Ayerbe, Cristina10 (AUTHOR), Brar, Indira11 (AUTHOR), Madruga, Jose Valdez12 (AUTHOR), Lu, Michael T13 (AUTHOR), Douglas, Pamela S14 (AUTHOR), Zanni, Markella V7 (AUTHOR), Grinspoon, Steven K7 (AUTHOR)
Source: Open Forum Infectious Diseases. Apr2025, Vol. 12 Issue 4, p1-11. 11p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:23288957
DOI:10.1093/ofid/ofaf177